基因表现市场－全球产业规模、份额、趋势、机会及预测，依製程、产品、产能、应用、技术、地区及竞争格局划分，2020-2030年预测

2024年全球基因表现市场规模为157.8亿美元，预计2030年将以5.58%的复合年增长率成长至218.6亿美元。基因表现是指将DNA中的遗传讯息转化为功能性基因产物（主要是蛋白质或RNA分子）的基本细胞过程，决定特定的细胞属性和功能。基因组研究和定序技术的不断进步、全球慢性病和传染病发病率的上升（需要精准的诊断和预后工具）以及生物製药研发领域为发现新型疗法而不断增长的投资，都显着推动了该市场的成长。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球基因表现市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依流程（样本采集、纯化、cDNA合成与转化、PCR分析、数据分析与解释）
  • 依产品分类（试剂盒及试剂、DNA晶片、其他）
  • 依容量划分（低至中 Plex，高 Plex）
  • 按应用领域（药物发现与开发、临床诊断、生物技术与微生物学、其他）
  • 依技术（RNA表现、启动子分析、蛋白质表现及翻译后修饰分析）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美基因表现市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲基因表现市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区基因表现市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲基因表现市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美基因表现市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球基因表现市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Catalent, Inc.
• Quest Diagnostics Incorporated
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• PerkinElmer, Inc.
• Thermo Fisher Scientific, Inc.
• Promega Corporation
• Luminex Corporation
• Takara Bio USA, Inc.
• Danaher Corporation

第十六章：策略建议

第17章调查会社について・免责事项

The Global Gene Expression Market, valued at USD 15.78 Billion in 2024, is projected to experience a CAGR of 5.58% to reach USD 21.86 Billion by 2030. Gene expression delineates the fundamental cellular process whereby genetic information from DNA is converted into functional gene products, primarily proteins or RNA molecules, thereby dictating specific cellular attributes and functions. The market's expansion is significantly propelled by continuous advancements in genomic research and sequencing technologies, the escalating global incidence of chronic and infectious diseases necessitating precise diagnostic and prognostic tools, and growing investments in biopharmaceutical research and development for novel therapeutic discovery.

Key Market Drivers

The global gene expression market is significantly influenced by continued advancements in genomics and biotechnology, which serve as foundational catalysts for innovation. These developments encompass sophisticated sequencing technologies, refined gene editing tools such as CRISPR, and comprehensive omics approaches, all of which enhance the depth and efficiency of gene expression analysis. This continuous evolution in scientific capabilities enables researchers to explore complex biological systems with unprecedented resolution, driving the discovery of new therapeutic targets and diagnostic biomarkers.

Key Market Challenges

A significant challenge impeding the growth of the Global Gene Expression Market is the substantial capital outlay required for advanced analysis platforms. Implementing high-throughput sequencing technologies and establishing complex bioinformatics infrastructure necessitates considerable upfront investment. This financial burden restricts broader adoption, particularly among smaller research entities, emerging biotechnology firms, and academic laboratories operating with limited budgets. Such high initial and ongoing maintenance costs can delay or prevent these organizations from acquiring essential equipment and developing the necessary expertise, thereby hindering the widespread application of gene expression technologies across various research and clinical domains.

Key Market Trends

The expansion of spatial transcriptomics significantly advances gene expression analysis by offering critical contextual information, enabling visualization of gene activity within its native tissue microenvironment. This capability is essential for unraveling intricate disease mechanisms, identifying precise therapeutic targets, and discovering biomarkers. Spatial transcriptomics provides insights into cellular heterogeneity and cell-to-cell interactions, fostering notable market growth. For instance, in June 2024, Moleculent AB secured USD 25.0 million in Series A financing to advance its spatial mapping of cell-cell communication. This development is supported by broader industry investment, with the European Federation of Pharmaceutical Industries and Associations reporting an estimated €50,000 million invested in research and development in Europe in 2023.

Key Market Players

• Catalent, Inc.
• Quest Diagnostics Incorporated
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• PerkinElmer, Inc.
• Thermo Fisher Scientific, Inc.
• Promega Corporation
• Luminex Corporation
• Takara Bio USA, Inc.
• Danaher Corporation

Report Scope:

In this report, the Global Gene Expression Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gene Expression Market, By Process:

• Sample Collection
• Purification
• cDNA synthesis & conversion
• PCR Analysis
• Data analysis & interpretation

Gene Expression Market, By Product:

• Kits & Reagents
• DNA Chips
• Others

Gene Expression Market, By Capacity:

• Low- to Mid- Plex
• High-Plex

Gene Expression Market, By Application:

• Drug Discovery & Development
• Clinical Diagnostics
• Biotech & Microbiology
• Others

Gene Expression Market, By Technique:

• RNA Expression
• Promoter Analysis
• Protein Expression& Posttranslational Modification Analysis

Gene Expression Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Gene Expression Market.

Available Customizations:

Global Gene Expression Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gene Expression Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Process (Sample Collection, Purification, cDNA synthesis & conversion, PCR Analysis, Data analysis & interpretation)
  • 5.2.2. By Product (Kits & Reagents, DNA Chips, Others)
  • 5.2.3. By Capacity (Low- to Mid- Plex, High-Plex)
  • 5.2.4. By Application (Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology, Others)
  • 5.2.5. By Technique (RNA Expression, Promoter Analysis, Protein Expression& Posttranslational Modification Analysis)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Gene Expression Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Process
  • 6.2.2. By Product
  • 6.2.3. By Capacity
  • 6.2.4. By Application
  • 6.2.5. By Technique
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Gene Expression Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Process
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Capacity
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By Technique
  • 6.3.2. Canada Gene Expression Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Process
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Capacity
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By Technique
  • 6.3.3. Mexico Gene Expression Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Process
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Capacity
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By Technique

7. Europe Gene Expression Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Process
  • 7.2.2. By Product
  • 7.2.3. By Capacity
  • 7.2.4. By Application
  • 7.2.5. By Technique
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Gene Expression Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Process
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Capacity
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By Technique
  • 7.3.2. France Gene Expression Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Process
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Capacity
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By Technique
  • 7.3.3. United Kingdom Gene Expression Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Process
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Capacity
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By Technique
  • 7.3.4. Italy Gene Expression Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Process
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Capacity
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By Technique
  • 7.3.5. Spain Gene Expression Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Process
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Capacity
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By Technique

8. Asia Pacific Gene Expression Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Process
  • 8.2.2. By Product
  • 8.2.3. By Capacity
  • 8.2.4. By Application
  • 8.2.5. By Technique
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Gene Expression Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Process
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Capacity
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By Technique
  • 8.3.2. India Gene Expression Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Process
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Capacity
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By Technique
  • 8.3.3. Japan Gene Expression Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Process
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Capacity
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By Technique
  • 8.3.4. South Korea Gene Expression Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Process
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Capacity
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By Technique
  • 8.3.5. Australia Gene Expression Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Process
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Capacity
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By Technique

9. Middle East & Africa Gene Expression Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Process
  • 9.2.2. By Product
  • 9.2.3. By Capacity
  • 9.2.4. By Application
  • 9.2.5. By Technique
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Gene Expression Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Process
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Capacity
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By Technique
  • 9.3.2. UAE Gene Expression Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Process
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Capacity
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By Technique
  • 9.3.3. South Africa Gene Expression Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Process
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Capacity
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By Technique

10. South America Gene Expression Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Process
  • 10.2.2. By Product
  • 10.2.3. By Capacity
  • 10.2.4. By Application
  • 10.2.5. By Technique
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Gene Expression Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Process
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Capacity
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By Technique
  • 10.3.2. Colombia Gene Expression Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Process
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Capacity
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By Technique
  • 10.3.3. Argentina Gene Expression Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Process
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Capacity
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By Technique

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Gene Expression Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Catalent, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Quest Diagnostics Incorporated
• 15.3. F. Hoffmann-La Roche Ltd
• 15.4. Illumina, Inc.
• 15.5. PerkinElmer, Inc.
• 15.6. Thermo Fisher Scientific, Inc.
• 15.7. Promega Corporation
• 15.8. Luminex Corporation
• 15.9. Takara Bio USA, Inc.
• 15.10. Danaher Corporation

16. Strategic Recommendations

17. About Us & Disclaimer